Literature DB >> 29974382

Mapping between HAQ-DI and EQ-5D-5L in a Chinese patient population.

Thomas Patton1, Hao Hu2, Luan Luan2, Keqin Yang3, Shu-Chuen Li2.   

Abstract

OBJECTIVES: In order to address the current deficiency of health utility evidence relevant for economic evaluations involving treatments for rheumatoid arthritis (RA) in the Chinese setting, this study aims to develop a mapping algorithm linking the Health Assessment Questionnaire (HAQ) and EQ-5D-5L in a Chinese population of patients with RA.
METHODS: An estimation sample was obtained from a cross-sectional study that collected HAQ, the pain Visual Analogue Scale, and EQ-5D-5L in RA patients in two tertiary referral hospitals in China. Mapping algorithms were derived in this study using two alternative regression methods: the beta regression and a multivariate ordered probit regression. The internal validity of the mapping algorithms was assessed in each case by calculating predictive performance using a bootstrapping procedure.
RESULTS: Of the several algorithms developed using these data, predictive performance was shown to be better when VAS pain was included as a predictor and when the multivariate ordered probit regression method was used, rather than the beta regression method. The algorithms developed were shown to be comparable, in terms of predictive performance, to existing mapping studies despite the small sample size of the estimation data.
CONCLUSION: It is hoped that the availability of these algorithms will facilitate the development of cost-effectiveness studies evaluating RA treatments in the Chinese health care setting.

Entities:  

Keywords:  Cost effectiveness; Health utilities; Mapping; Rheumatoid arthritis

Mesh:

Year:  2018        PMID: 29974382      PMCID: PMC6208580          DOI: 10.1007/s11136-018-1925-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  41 in total

1.  Does disease activity add to functional disability in estimation of utility for rheumatoid arthritis patients on biologic treatment?

Authors:  Sandhya C Nair; Paco M J Welsing; Anne Karien C A Marijnissen; Paulina Sijtsma; Johannes W J Bijlsma; Jacob M van Laar; Floris P J G Lafeber; G Ardine de Wit
Journal:  Rheumatology (Oxford)       Date:  2015-08-27       Impact factor: 7.580

Review 2.  International comparisons in valuing EQ-5D health states: a review and analysis.

Authors:  Richard Norman; Paula Cronin; Rosalie Viney; Madeleine King; Deborah Street; Julie Ratcliffe
Journal:  Value Health       Date:  2009-08-20       Impact factor: 5.725

3.  Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.

Authors:  Ben van Hout; M F Janssen; You-Shan Feng; Thomas Kohlmann; Jan Busschbach; Dominik Golicki; Andrew Lloyd; Luciana Scalone; Paul Kind; A Simon Pickard
Journal:  Value Health       Date:  2012-05-24       Impact factor: 5.725

4.  Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis.

Authors:  Siri Lillegraven; Ivar Sønbø Kristiansen; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2010-05-06       Impact factor: 19.103

5.  Psychometric validation of Chinese Health Assessment Questionnaire for use in rheumatoid arthritis patients in China.

Authors:  Hao Hu; Luan Luan; Keqin Yang; Shu-Chuen Li
Journal:  Int J Rheum Dis       Date:  2016-03-01       Impact factor: 2.454

6.  The State of Cost-Utility Analyses in Asia: A Systematic Review.

Authors:  Teja Thorat; Pei-Jung Lin; Peter J Neumann
Journal:  Value Health Reg Issues       Date:  2015-03-24

7.  The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.

Authors:  J F Fries; P W Spitz; D Y Young
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

8.  Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data.

Authors:  Hye-Lin Kim; Dam Kim; Eun Jin Jang; Min-Young Lee; Hyun Jin Song; Sun-Young Park; Soo-Kyung Cho; Yoon-Kyoung Sung; Chan-Bum Choi; Soyoung Won; So-Young Bang; Hoon-Suk Cha; Jung-Yoon Choe; Won Tae Chung; Seung-Jae Hong; Jae-Bum Jun; Jinseok Kim; Seong-Kyu Kim; Tae-Hwan Kim; Tae-Jong Kim; Eunmi Koh; Hwajeong Lee; Hye-Soon Lee; Jisoo Lee; Shin-Seok Lee; Sung Won Lee; Sung-Hoon Park; Seung-Cheol Shim; Dae-Hyun Yoo; Bo Young Yoon; Sang-Cheol Bae; Eui-Kyung Lee
Journal:  Rheumatol Int       Date:  2016-02-06       Impact factor: 2.631

Review 9.  Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database.

Authors:  Helen Dakin
Journal:  Health Qual Life Outcomes       Date:  2013-09-05       Impact factor: 3.186

10.  Consensus Decision Models for Biologics in Rheumatoid and Psoriatic Arthritis: Recommendations of a Multidisciplinary Working Party.

Authors:  Jason Madan; Tony Ades; Pelham Barton; Laura Bojke; Ernest Choy; Philip Helliwell; Paresh Jobanputra; Ken Stein; Andrew Stevens; Jonathan Tosh; Suzanne Verstappen; Allan Wailoo
Journal:  Rheumatol Ther       Date:  2015-11-25
View more
  1 in total

1.  Tofacitinib in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in China: A Cost-Effectiveness Analysis Based on a Mapping Algorithm Derived from a Chinese Population.

Authors:  Chongqing Tan; Sini Li; Lidan Yi; Xiaohui Zeng; Liubao Peng; Shuxia Qin; Liting Wang; Xiaomin Wan
Journal:  Adv Ther       Date:  2021-04-10       Impact factor: 3.845

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.